Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 123

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 123
---
 file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes, may lawfully do or cause to be done by virtue thereof. 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. 

    Signature
     
    Title
     
    Date

    /s/ Kevin R. M. Smith
     
    Chief Executive Officer, President and Director
     
    February 28, 2025

    Kevin R. M. Smith
     
    (Principal Executive Officer)

    /s/ Michael Bourque
     
    Chief Financial Officer
     
    February 28, 2025

    Michael Bourque
     
    (Principal Accounting and Financial Officer)

    /s/ Elizabeth Mora
     
    Chairperson of the Board
     
    February 28, 2025

    Elizabeth Mora

    /s/ Glenn Boehnlein
     
    Director
     
    February 28, 2025

    Glenn Boehnlein

    /s/ Kevin King
     
    Director
     
    February 28, 2025

    Kevin King

    /s/ Mary Katherine Ladone
     
    Director
     
    February 28, 2025

    Mary Katherine Ladone

    /s/ Heather Rider
     
    Director
     
    February 28, 2025

    Heather Rider

    /s/ Mira Sahney
     
    Director
     
    February 28, 2025

    Mira Sahney

 82